SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients

Abstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC...

Full description

Bibliographic Details
Main Authors: Hairu Yu, Jiayi Sun, Congxuan Zhao, Haotian Wang, Yeqiu Liu, Jiajia Xiong, Jing Chang, Mixue Wang, Wenhui Wang, Dongman Ye, Hongyan Zhou, Tao Yu
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-019-5944-2
id doaj-32550c4e0f594b7e82bdbbf1a8adab63
record_format Article
spelling doaj-32550c4e0f594b7e82bdbbf1a8adab632020-11-25T02:48:04ZengBMCBMC Cancer1471-24072019-07-0119111010.1186/s12885-019-5944-2SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patientsHairu Yu0Jiayi Sun1Congxuan Zhao2Haotian Wang3Yeqiu Liu4Jiajia Xiong5Jing Chang6Mixue Wang7Wenhui Wang8Dongman Ye9Hongyan Zhou10Tao Yu11Department of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityThe First Clinical College, Dalian Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityAbstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC. Methods SETD5 was detected by immunohistochemical analysis in 147 patients with non-small cell lung cancer. SETD5 was overexpressed in A549 cells or suppressed with siRNA in H1299 cells. Wound healing and transwell assays were performed. The expression levels of SETD5, p-AKT/AKT, Snail, p-JNK/JNK, Slug, E-cadherin, Zo-1, p-P38/P38, occludin, α-catenin, p-ERK/ERK, and p-P90RSK/ P90RSK were assessed by western blot. Results Online analysis of overall survival in 1928 patients with NSCLC showed that the SETD5 gene was related to worse overall survival (OS)(P < 0.001). The positive expression rate of SETD5 in noncancerous tissues was lower than that in cancerous tissues (16.7% vs. 44.2%, P < 0.001). SETD5 was significantly correlated with advanced TNM stage (P < 0.001), lymph node metastasis (P < 0.001) and overall survival rate (P < 0.001). Overexpression of SETD5 in A549 cells increased migration and invasion, while deletion of SETD5 in H1299 cells decreased migration and invasion. After overexpression of SETD5, the expression of ZO-1 was downregulated, and that of Snail was upregulated. After overexpression of SETD5, the levels of p-ERK and its downstream factor p-p90rsk increased. Conclusion These results suggest that SETD5 could regulate p-P90RSK and facilitate the migration and invasion of NSCLC and may be related to the poor prognosis of patients with NSCLC.http://link.springer.com/article/10.1186/s12885-019-5944-2SET domain containing 5 (SETD5)Non-small cell lung cancerInvasionERK signalingPrognosis
collection DOAJ
language English
format Article
sources DOAJ
author Hairu Yu
Jiayi Sun
Congxuan Zhao
Haotian Wang
Yeqiu Liu
Jiajia Xiong
Jing Chang
Mixue Wang
Wenhui Wang
Dongman Ye
Hongyan Zhou
Tao Yu
spellingShingle Hairu Yu
Jiayi Sun
Congxuan Zhao
Haotian Wang
Yeqiu Liu
Jiajia Xiong
Jing Chang
Mixue Wang
Wenhui Wang
Dongman Ye
Hongyan Zhou
Tao Yu
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
BMC Cancer
SET domain containing 5 (SETD5)
Non-small cell lung cancer
Invasion
ERK signaling
Prognosis
author_facet Hairu Yu
Jiayi Sun
Congxuan Zhao
Haotian Wang
Yeqiu Liu
Jiajia Xiong
Jing Chang
Mixue Wang
Wenhui Wang
Dongman Ye
Hongyan Zhou
Tao Yu
author_sort Hairu Yu
title SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
title_short SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
title_full SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
title_fullStr SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
title_full_unstemmed SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
title_sort set domain containing protein 5 (setd5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2019-07-01
description Abstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC. Methods SETD5 was detected by immunohistochemical analysis in 147 patients with non-small cell lung cancer. SETD5 was overexpressed in A549 cells or suppressed with siRNA in H1299 cells. Wound healing and transwell assays were performed. The expression levels of SETD5, p-AKT/AKT, Snail, p-JNK/JNK, Slug, E-cadherin, Zo-1, p-P38/P38, occludin, α-catenin, p-ERK/ERK, and p-P90RSK/ P90RSK were assessed by western blot. Results Online analysis of overall survival in 1928 patients with NSCLC showed that the SETD5 gene was related to worse overall survival (OS)(P < 0.001). The positive expression rate of SETD5 in noncancerous tissues was lower than that in cancerous tissues (16.7% vs. 44.2%, P < 0.001). SETD5 was significantly correlated with advanced TNM stage (P < 0.001), lymph node metastasis (P < 0.001) and overall survival rate (P < 0.001). Overexpression of SETD5 in A549 cells increased migration and invasion, while deletion of SETD5 in H1299 cells decreased migration and invasion. After overexpression of SETD5, the expression of ZO-1 was downregulated, and that of Snail was upregulated. After overexpression of SETD5, the levels of p-ERK and its downstream factor p-p90rsk increased. Conclusion These results suggest that SETD5 could regulate p-P90RSK and facilitate the migration and invasion of NSCLC and may be related to the poor prognosis of patients with NSCLC.
topic SET domain containing 5 (SETD5)
Non-small cell lung cancer
Invasion
ERK signaling
Prognosis
url http://link.springer.com/article/10.1186/s12885-019-5944-2
work_keys_str_mv AT hairuyu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT jiayisun setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT congxuanzhao setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT haotianwang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT yeqiuliu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT jiajiaxiong setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT jingchang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT mixuewang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT wenhuiwang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT dongmanye setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT hongyanzhou setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
AT taoyu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients
_version_ 1724750230261334016